Evidence map›Paper›PMID 33478959›Full record

ReviewArchives of disease in childhood. Fetal and neonatal edition2021

Management of systemic hypotension in term infants with persistent pulmonary hypertension of the newborn: an illustrated review.

Heather M Siefkes, Satyan Lakshminrusimha

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Archives of disease in childhood. Fetal and neonatal edition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07322133 (Dopamine vs. Norepinephrine in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure and Systemic Hypotension Due to Pulmonary Hypertension), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07322133 phase4recruitingnot on this mapstarted 2026, after this paper: background citation

Dopamine vs. Norepinephrine in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure and Systemic Hypotension Due to Pulmonary Hypertension: A Pilot Trial

TypeinterventionalSponsorUniversity of California, DavisRan2026 to 2027Enrolled30ConditionsHypotension and Shock, Pulmonary Hypertension of the Newborn (PPHN), Hypoxemic Respiratory FailureArmsDopamine administration, Norepinephrine
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Heather M SiefkesDepartment of Pediatrics, UC Davis, Sacramento, California, USA hsiefkes@ucdavis.edu.
Satyan LakshminrusimhaDepartment of Pediatrics, UC Davis, Sacramento, California, USA.ORCID http://orcid.org/0000-0001-6098-2155
UC Davis Children's Hospital · US

Funding

UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
Institutional Career Development Core (KL2)KL2TR001859 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HOLMES, JAMES F. · 2016 to 2025
$10.1M
Optimal Oxygenation in Neonatal Lung InjuryR01HD072929 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Satyanarayana Lakshminrusimha · 2012 to 2026
$5.4M
Improving Critical Congenital Heart Disease Screening and Detection of "Secondary" TargetsR21HD099239 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SIEFKES, HEATHER M · 2019 to 2020
$433k
NCATS NIH HHS KL2 TR001859NCATS NIH HHS UL1 TR001860NICHD NIH HHS R01 HD072929NICHD NIH HHS R21 HD099239
6 · The paper itself

Abstract

In persistent pulmonary hypertension of the newborn (PPHN), the ratio of pulmonary vascular resistance to systemic vascular resistance is increased. Extrapulmonary shunts (patent ductus arteriosus and patent foramen value) allow for right-to-left shunting and hypoxaemia. Systemic hypotension can occur in newborns with PPHN due to variety of reasons, such as enhanced peripheral vasodilation, impaired left ventricular function and decreased preload. Systemic hypotension can lead to end organ injury from poor perfusion and hypoxaemia in the newborn with PPHN. Thus, it must be managed swiftly. However, not all newborns with PPHN and systemic hypotension can be managed the same way. Individualised approach based on physiology and echocardiographic findings are necessary to improve perfusion to essential organs. Here we present a review of the physiology and mechanisms of systemic hypotension in PPHN, which can then guide treatment.

Indexed as

Blood Pressure MonitorsExtracorporeal Membrane OxygenationFluid TherapyHemodynamicsHumansHypotensionInfant, NewbornPersistent Fetal Circulation SyndromePractice Guidelines as TopicVasoconstrictor AgentsVasoconstrictor Agentscardiologyneonatology

Identifiers

PMID33478959
PMCPMC8217132
OpenAlexW3125557232

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.